MétaCan
Menu
Back to cohort
Record W4382199204 · doi:10.1093/jnci/djad116

Contralateral breast cancer risk in patients with breast cancer and a germline-<i>BRCA1/2</i> pathogenic variant undergoing radiation

2023· article· en· W4382199204 on OpenAlexafffund
Mark van Barele, Delal Akdeniz, Bernadette A. M. Heemskerk‐Gerritsen, Nadine Andrieu, Catherine Noguès, Christi J. van Asperen, Marijke R. Wevers, Margreet G.E.M. Ausems, Geertruida H. de Bock, Charlotte J. Dommering, E. Gómez, Flora E. van Leeuwen, Thea M. Mooij, Douglas F. Easton, Antonis C. Antoniou, D. Gareth Evans, Louise Izatt, Marc Tischkowitz, Debra Frost, Carole Brewer, Edith Oláh, Jacques Simard, Christian F. Singer, Mads Thomassen, Karin Kast, Kerstin Rhiem, Christoph Engel, Miguel de la Hoya, Lenka Foretová, Anna Jakubowska, Agnes Jager, M. Sattler, Marjanka K. Schmidt, Maartje J. Hooning

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversité LavalCentre hospitalier universitaire de QuébecMcGill University
FundersCentre Léon BérardInstitut Claudius RegaudInstitut National Du CancerDirection Générale de l’offre de SoinsMedizinische Universität WienLeids Universitair Medisch CentrumMinisterio de Ciencia e InnovaciónMaastricht Universitair Medisch CentrumOdense UniversitetshospitalRadboud Universitair Medisch CentrumFondation de FranceGreat Ormond Street Hospital for ChildrenRijksuniversiteit GroningenMinisterio de Economía y CompetitividadNederlandse Organisatie voor Wetenschappelijk OnderzoekInstitut Gustave-RoussyErasmus Medisch CentrumVrije Universiteit AmsterdamInstituto de Salud Carlos IIIRadboud UniversiteitNewcastle upon Tyne Hospitals NHS Foundation TrustUniversiteit LeidenInstitut BergoniéDeutsche KrebshilfeUniversity of GlasgowMinistero dello Sviluppo EconomicoUniversiteit van AmsterdamKWF KankerbestrijdingNottingham University Hospitals NHS TrustCancer Research UKUniversity of SouthamptonBundesministerium für Bildung und ForschungMinistère du Développement Économique, de l’Innovation et de l’ExportationNational Institute for Health and Care ResearchUniversity of NottinghamCentral Manchester University Hospitals NHS Foundation TrustUniversität WienNational Institute on Handicapped ResearchAmsterdam University Medical CentersUniversiteit MaastrichtFondation ARC pour la Recherche sur le CancerRoyal Marsden NHS Foundation TrustCanadian Institutes of Health ResearchFundación Mutua Madrileña
KeywordsMedicineBreast cancerInternal medicineHazard ratioOncologyProportional hazards modelConfidence intervalProspective cohort studyRadiation therapyCancerGastroenterology

Abstract

fetched live from OpenAlex

BACKGROUND: Radiation-induced secondary breast cancer (BC) may be a concern after radiation therapy (RT) for primary breast cancer (PBC), especially in young patients with germline (g)BRCA-associated BC who already have high contralateral BC (CBC) risk and potentially increased genetic susceptibility to radiation. We sought to investigate whether adjuvant RT for PBC increases the risk of CBC in patients with gBRCA1/2-associated BC. METHODS: The gBRCA1/2 pathogenic variant carriers diagnosed with PBC were selected from the prospective International BRCA1/2 Carrier Cohort Study. We used multivariable Cox proportional hazards models to investigate the association between RT (yes vs no) and CBC risk. We further stratified for BRCA status and age at PBC diagnosis (<40 and >40 years). Statistical significance tests were 2-sided. RESULTS: Of 3602 eligible patients, 2297 (64%) received adjuvant RT. Median follow-up was 9.6 years. The RT group had more patients with stage III PBC than the non-RT group (15% vs 3%, P < .001), received chemotherapy more often (81% vs 70%, P < .001), and received endocrine therapy more often (50% vs 35%, P < .001). The RT group had an increased CBC risk compared with the non-RT group (adjusted hazard ratio [HR] = 1.44; 95% confidence interval [CI] = 1.12 to 1.86). Statistical significance was observed in gBRCA2 (HR = 1.77; 95% CI = 1.13 to 2.77) but not in gBRCA1 pathogenic variant carriers (HR = 1.29; 95% CI = 0.93 to 1.77; P = .39 for interaction). In the combined gBRCA1/2 group, patients irradiated when they were younger than or older than 40 years of age at PBC diagnosis showed similar risks (HR = 1.38; 95% CI = 0.93 to 2.04 and HR = 1.56; 95% CI = 1.11 to 2.19, respectively). CONCLUSIONS: RT regimens minimizing contralateral breast dose should be considered in gBRCA1/2 pathogenic variant carriers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.265
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicBRCA gene mutations in cancerFrench-language works237,207